---
DrugClass: "[[Cholinergic Blocking Drugs]]"
SubClass: "[[Cholinergic Blocking Drugs for Nonacute Respiratory Symptom Relief]]"
DrugClassContra: "[[Cholinergic Blocking Drugs#Contraindications]]"
DrugClassAdverse: "[[Cholinergic Blocking Drugs#Side/Adverse Effects]]"
SecondaryDrugClass: "[[Lower Respiratory System Drugs]]"
SecondarySubClass: "[[Bronchodilators]]"
BrandName: Atrovent
Chapter: "26"
KindleLinkChap: "[Chapter 26](kindle://book?action=open&asin=B09FRF11YJ&location=13703)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
Bronchospasm associated with chronic obstructive pulmonary disease, chronic bronchitis and emphysema, rhinorrhea 
Aerosol: 2 inhalations QID, not to exceed 12 inhalations; Solution: 500 mg (1 unit dose vial) TID, QID by oral nebulization 
Nasal spray: 2 sprays per nostril BID, TID of 0.03%, or 2 sprays per nostril TID, QID of 0.06%
### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
Dryness of the [[Oropharynx]], nervousness, irritation from aerosol, dry [[Mouth]], runny nose, upper [[Respiratory]] symptoms (URI), dizziness, headache, GI distress, nausea, palpitations

### Interactions

`= this.ChemLink+this.file.name`

